RENAVANCE PHARMA, INC.

Profile

Company Names

RENAVANCE PHARMA, INC.

Addresses

330 DEERTRAIL LANE, MILL VALLEY, CA 94941

Phone Numbers

415 378-4099

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2009

State Incorporated:

DELAWARE

Total Amount Raised:

$600,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2010-07-28 
$100,000.00 
$100,000.00 
$0.00 
Equity, Debt 
1
2009-07-01 
$500,000.00 
$500,000.00 
$0.00 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ANDREW 
 
BUSSER 
DIRECTOR
GLIAMED INC   |  RENAVANCE PHARMA, INC.
JOHN 
 
DONOVAN 
EXECUTIVE OFFICER, DIRECTOR
LENDINGCLUB CORP   |  RENAVANCE PHARMA, INC.   |  ALIOS BIOPHARMA INC   |  TIOMA THERAPEUTICS, INC.   |  CONCENTRIC ANALGESICS, INC.   |  OLEA NETWORKS, INC.   |  TOLERION, INC.   |  LUCATA CORP   |  NOVASIGNAL CORP.   |  CRESTA INTELLIGENCE INC.   |  HUNTINGTON FERMI FUSION, LLC
MARK 
 
KESSEL 
DIRECTOR
RENAVANCE PHARMA, INC.   |  DYNAVAX TECHNOLOGIES CORP   |  OXIGENE INC   |  PRIMROSE THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2010-08-06
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2010-07-28 
2009-07-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2009-07-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#